Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Annelore Altendorf‐Hofmann"'
Autor:
Jennifer Kosinski, Antonio Sechi, Johanna Hain, Sophia Villwock, Stefanie Anh Ha, Maximilian Hauschulz, Michael Rose, Florian Steib, Nadina Ortiz‐Brüchle, Lara Heij, Sanne L. Maas, Emiel P. C. van derVorst, Thomas Knoesel, Annelore Altendorf‐Hofmann, Ronald Simon, Guido Sauter, Jan Bednarsch, Danny Jonigk, Edgar Dahl
Publikováno v:
Molecular Oncology, Vol 18, Iss 6, Pp 1486-1509 (2024)
Inter‐alpha‐trypsin inhibitor heavy chain 5 (ITIH5) has been identified as a metastasis suppressor gene in pancreatic cancer. Here, we analyzed ITIH5 promoter methylation and protein expression in The Cancer Genome Atlas (TCGA) dataset and three
Externí odkaz:
https://doaj.org/article/75b2e5c402634669a62206e5036d9a5a
Autor:
Daniel Kaemmerer, Robin Schindler, Franziska Mußbach, Uta Dahmen, Annelore Altendorf-Hofmann, Olaf Dirsch, Jörg Sänger, Stefan Schulz, Amelie Lupp
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-14 (2017)
Abstract Background Hepatocellular (HCC) and cholangiocellular carcinomas (CCC) display an exceptionally poor prognosis. Especially for advanced disease no efficient standard therapy is currently available. Recently, somatostatin analogs have been ev
Externí odkaz:
https://doaj.org/article/e54bffdf432d41d08ba56095de5a89a4
Autor:
Emanuel Stutz, Rolf D. Issels, Ulrich Mansmann, Michael Schmidt, Elfriede Noessner, Lars H. Lindner, Thomas Knoesel, S. Abdel-Rahman, Annelore Altendorf-Hofmann, Veit Buecklein, Jean-Yves Blay, Markus Albertsmeier, Michael von Bergwelt-Baildon, Yujun Xu
Publikováno v:
European Journal of Cancer. 158:123-132
BACKGROUND The EORTC 62961-ESHO 95 randomised trial showed improved long-term survival of patients with high-risk soft-tissue sarcoma by adding regional hyperthermia to neoadjuvant chemotherapy. We hypothesised that immune infiltrate of patients trea
Autor:
Luc M. Berclaz, Annelore Altendorf-Hofmann, Lars H. Lindner, Anton Burkhard-Meier, Dorit Di Gioia, Hans Roland Dürr, Alexander Klein, Markus Albertsmeier, Nina-Sophie Schmidt-Hegemann, Frederick Klauschen, Thomas Knösel
Publikováno v:
Cancers; Volume 15; Issue 10; Pages: 2735
(1) Background: The expression of T cell immunoglobulin and mucin domain-containing protein 3 (TIM-3), an immune checkpoint receptor on T cells, has been associated with dismal outcomes and advanced tumor stages in various solid tumors. The blockade
Autor:
Annelore Altendorf-Hofmann, Utz Settmacher, Herman Kissler, Hans-Michael Tautenhahn, Aladdin Ali Deeb, A. Bauschke
Publikováno v:
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
The role of surgical treatment of hepato-pancreatic metastases from renal cell carcinoma is still under discussion.We report about 52 patients of whom 33 underwent surgery for liver metastases and 19 for pancreatic metastases from 1995 to 2018.The 5
Autor:
Utz Settmacher, Herman Kissler, Annelore Altendorf-Hofmann, A. Bauschke, Michael Ardelt, Hans-Michael Tautenhahn
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Background It has been shown that local ablative procedures enable downsizing, reduce drop-out from the waiting list and improve prognosis after liver transplantation. It is still unclear whether a response to the local ablative therapy is due to a f
Autor:
Martin F. Orth, Marion Subklewe, Thomas G. P. Grunewald, Eric Kampmann, Rolf D. Issels, Thomas Knösel, Thomas Kirchner, Laura Romero-Pérez, Elfriede Noessner, Fabienne S. Wehweck, Florencia Cidre-Aranaz, Annelore Altendorf-Hofmann, Veit Buecklein, Lars H. Lindner
Publikováno v:
Cancer Immunology, Immunotherapy. 69:1353-1362
Soft tissue sarcomas (STSs) are heterogeneous cancers associated with poor prognosis due to high rates of local recurrence and metastasis. The programmed death receptor ligand 1 (PD-L1) is expressed in several cancers. PD-L1 interacts with its recept
Autor:
A. Bauschke, Annelore Altendorf-Hofmann, Utz Settmacher, Robert Drescher, Lukas Brückner, Martin Freesmeyer
Background Tumor recurrence is the leading cause of death after liver transplantation in patients with hepatocellular carcinoma. There is an ongoing debate as to whether metabolic indices such as tumor to liver standardized uptake value ratio in 18F-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9c7591a166c80f2c6b1c9f60d6d5591
https://doi.org/10.21203/rs.3.rs-1033896/v1
https://doi.org/10.21203/rs.3.rs-1033896/v1
Autor:
Astrid, Bauschke, Annelore, Altendorf-Hofmann, Lukas, Brückner, Robert, Drescher, Martin, Freesmeyer, Utz, Settmacher
Publikováno v:
Journal of cancer research and clinical oncology.
Tumor recurrence is the leading cause of death after liver transplantation in patients with hepatocellular carcinoma. There is an ongoing debate as to whether metabolic indices such as tumor to liver standardized uptake value ratio inThis retrospecti
Autor:
Utz Settmacher, Annelore Altendorf-Hofmann, A. Bauschke, Jörg Pertschy, Hubert Göbel, Thomas Manger, Merten Homman, Herry Helfritzsch
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Introduction In the literature, results after surgical treatment of non-colorectal non-neuroendocrine liver metastases (NCNNLM) are reported that are often inferior to those from colorectal liver metastases. The selection of patients with favorable t